The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -70.70%. However, over the past six months, we’ve seen a stronger performance of -71.91%. The price of CGTX fallen by 28.83% over the last 30 days. And in the last five days, it has surged by 14.92%.
The market performance of Cognition Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $2.95 on 05/23/24, while the lowest value for the same duration was $0.34 on 10/11/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of CGTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Cognition Therapeutics Inc’s current trading price is -81.62% away from its 52-week high, while its distance from the 52-week low is 59.44%. The stock’s price range during this period has varied between$0.34 and $2.95. The Cognition Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.93 million for the day, a figure considerably lower than their average daily volume of 1.19 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Cognition Therapeutics Inc (CGTX) has experienced a quarterly decline of -50.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 21.75M and boasts a workforce of 28 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0661, with a change in price of -1.3579. Similarly, Cognition Therapeutics Inc recorded 836,322 in trading volume during the last 100 days, posting a change of -71.47%.
CGTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CGTX stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
CGTX Stock Stochastic Average
As of today, Cognition Therapeutics Inc’s raw stochastic average for the last 50 days stands at 42.14%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 65.19%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 72.78% and 77.21%, respectively.
